Document:

Form of 2007 Incentive Plan Option Certificate

 Exhibit 10.18 
 2007 INCENTIVE PLAN OPTION CERTIFICATE 
 Optionee: 
 This Option and any securities issued upon exercise of this Option are subject to restrictions on voting and transfer and requirements of sale and
other provisions as set forth in the Stockholders Agreement among CRC Health Group, Inc. and certain investors, dated as of February 6, 2006, as amended from time to time (the “Stockholders Agreement”). This Option and any securities
issued upon exercise of this Option constitute Management Shares as defined therein. 
 CRC HEALTH GROUP, INC. 
 STOCK OPTION 
 CERTIFICATE 

This stock option (the “Agreement”) was granted by CRC Health Group, Inc., a Delaware corporation (the “Company”), to the
Optionee, pursuant to the Company’s 2007 Incentive Plan, as amended from time to time (the “Plan”). For purposes of this Agreement, the “Grant Date” shall mean
                     and the “Initial Vesting Date” shall mean
                    . 
 1. Grant of
Option. This certificate evidences the grant by the Company on the Grant Date to the Optionee of an option to purchase (the “Option”), in whole or in part, on the terms provided herein and in the Plan, the following Units as set forth
below. 
  

	 	(a)	[    ] Units at $         per Unit (the “Tranche 1 Options”); 

  

	 	(b)	[    ] Units at $         per Unit (the “Tranche 2 Options”); and 

  

	 	(c)	[    ] Units at $         per Unit (the “Tranche 3 Options” and together with the Tranche 1 Options and
Tranche 2 Options, the “Options”). 

 Each “Unit” consists of 9 shares of Class A Common Stock of the
Company, par value $.001 per share, and 1 share of Class L Common Stock of the Company, par value $.001 per share, subject to adjustment as provided in the Plan. The Option evidenced by this certificate is not intended to qualify as an incentive
stock option under Section 422 of the Internal Revenue Code (the “Code”). 
 2. Vesting. During the Optionee’s Employment, this
Option shall vest as follows: 
  

	 	(a)	The Tranche 1 Options will vest and become exercisable (i) with respect to 20% of the Units subject to the Tranche 1 Options on the first anniversary of the Initial Vesting
Date, (ii) with respect to 10% of the Units subject to the Tranche 1 Options every six months following the first anniversary of the Initial Vesting Date until 100% of the Tranche 1 Options are vested and (ii) if earlier, with respect to
100% of the Units subject to the Tranche 1 Options, on a Change of Control. 

	 	(b)	If a Tranche 2 Vesting Event occurs on a Measurement Date, then all or a portion of the Tranche 2 Options will vest and become exercisable such that the Tranche 2 Options will then
be vested and exercisable with respect to a number of Units equal to (i) the Tranche 2 Maximum Percentage with respect to such Measurement Date multiplied by (ii) the number of Units subject to the Tranche 2 Options.

  

	 	(c)	Prior to a Change of Control, the Tranche 3 Options will vest and become exercisable in installments on March 31, 2008, March 31, 2009, March 31,
2010, March 31, 2011, and March 31, 2012 with respect to a number of Units equal to (i) the Vesting Percentage for the previous calendar year multiplied by the number of Units subject to the Tranche 3 Options plus (ii) the
Catch-up Vesting Percentage for the previous calendar year multiplied by the number of Units subject to the Tranche 3 Options. In addition, on a Change of Control, unvested Tranche 3 Options will vest with respect to a number of Units equal to the
product of (i) the Average Vesting Percentage multiplied by (iii) the number of Undetermined Years multiplied by (iii) the number of Units subject to the Tranche 3 Options. Furthermore, if a Tranche 3 Vesting Event occurs on a
Measurement Date, then all Tranche 3 Options remaining unvested at such time will vest. 

 3. Exercise of Option. Each election to
exercise this Option shall be subject to the terms and conditions of the Plan and shall be in writing, signed by the Optionee or by his or her executor or administrator or by the person or persons to whom this Option is transferred by will or the
applicable laws of descent and distribution (the “Legal Representative”), and made pursuant to and in accordance with the terms and conditions set forth in the Plan. The latest date on which this Option may be exercised (the “Final
Exercise Date”) is the date which is the tenth (10th) anniversary of the Grant Date, subject to earlier termination in accordance with the terms and provisions of the Plan and this Agreement. 
 4. Representations and Warranties of Optionee. 
 Optionee represents and warrants that: 
  

	 	(a)	Authorization. Optionee has full legal capacity, power, and authority to execute and deliver this Agreement and to perform Optionee's obligations hereunder. This Agreement
has been duly executed and delivered by Optionee and is the legal, valid, and binding obligation of Optionee enforceable against Optionee in accordance with the terms hereof. 

  

	 	(b)	No Conflicts. The execution, delivery, and performance by Optionee of this Agreement and the consummation by Optionee of the transactions contemplated hereby will not, with
or without the giving of notice or lapse of time, or both (i) violate any provision of law, statute, rule or regulation to which Optionee is subject, (ii) violate any order, judgment or decree applicable to Optionee, or (iii) conflict
with, or result in a breach of default under, any term or condition of any agreement or other instrument to which Optionee is a party or by which Optionee is bound. 

  

 -2- 

	 	(c)	No Other Agreements. Except as provided by this Agreement, the Stockholders Agreement and the Plan, Optionee is not a party to or subject to any agreement or arrangement with
respect to the voting or transfer of this Option or the shares of common stock issued upon exercise hereof. 

  

	 	(d)	Thorough Review, etc. Optionee has thoroughly reviewed the Plan and this Agreement in their entirety. Optionee has had an opportunity to obtain the advice of counsel (other
than counsel to the Company or its Affiliates) prior to executing this Agreement, and fully understands all provisions of the Plan and this Agreement. 

  

	 	(e)	Investment Intent. The Optionee is acquiring the Units solely for the Optionee’s own account for investment and not with a view to or for sale in connection with
any distribution of the Units or any portion thereof and not with any present intention of selling, offering to sell or otherwise disposing of or distributing the Units or any portion thereof in any transaction other than a transaction exempt from
registration under the Securities Act. The Optionee further represents that the entire legal and beneficial interest of the Units is being acquired, and will be held, for the account of the Optionee only and neither in whole nor in part for any
other person. 

  

	 	(f)	Absence of Solicitation. The Optionee was not presented with or solicited by any form of general solicitation or general advertising, including, but not limited to,
any advertisement, article, notice, or other communication published in any newspaper, magazine, or similar media, or broadcast over television, radio or similar communications media, or presented at any seminar or meeting whose attendees have been
invited by any general solicitation or general advertising. 

  

	 	(g)	Residence. The Optionee’s principal residence is located at the address indicated beneath the Optionee’s signature below. 

  

	 	(h)	Information Concerning the Company. The Optionee is aware of the Company’s business affairs and financial condition and has acquired sufficient information about
the Company to reach an informed and knowledgeable decision to acquire the Units. The Optionee further represents and warrants that the Optionee has discussed the Company and its plans, operations and financial condition with its officers, has
received all such information as the Optionee deems necessary and appropriate to enable the Optionee to evaluate the financial risk inherent in acquiring the Units and has received satisfactory and complete information concerning the business and
financial condition of the Company in response to all inquiries in respect thereof. 

  

	 	(i)	 Capacity to Protect Interests. The Optionee has either (i) a preexisting personal or business relationship with the Company or any of its
officers, directors, or 

  

 -3- 

	 	 
controlling persons, consisting of personal or business contacts of a nature and duration to enable the Optionee to be aware of the character, business
acumen and general business and financial circumstances of the person with whom such relationship exists, or (ii) such knowledge and experience in financial and business matters as to make the Optionee capable of evaluating the merits and risks
of an investment in the Stock and to protect the Optionee’s own interests in the transaction, or (iii) both such relationship and such knowledge and experience. 

  

	 	(j)	Reliance by the Company. The Optionee understands that the Option and any Units acquired upon exercise of the Option have not been qualified under the Corporate
Securities Law of 1968, as amended, of the State of California by reason of a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Optionee’s representations as expressed herein. The
Optionee understands that the Company is relying on the Optionee’s representations and warrants that the Company is entitled to rely on such representations and that such reliance is reasonable. 

 5. Other Agreements. Optionee acknowledges and agrees that the shares received upon exercise of this Option shall be subject to the Stockholders Agreement
and the transfer and other restrictions, rights, and obligations set forth therein. By executing this Agreement, Optionee hereby becomes a party to and bound by the Stockholders Agreement as a Manager (as such term is defined in the Stockholders
Agreement), without any further action on the part of Optionee, the Company or any other person. 
 6. Legends. Certificates evidencing any shares
issued upon exercise of the Option granted hereby may bear the following legends, in addition to any legends which may be required by the Stockholders Agreement: 
 “The securities represented by this certificate were issued in a private placement, without registration under the Securities Act of 1933, as amended (the “Act”), and may not be sold, assigned, pledged,
or otherwise transferred in the absence of an effective registration under the Act covering the transfer or an opinion of counsel, satisfactory to the issuer, that registration under the Act is not required.” 
 7. Withholding. No Units will be transferred pursuant to the exercise of this Option unless and until the person exercising this Option shall have remitted to the
Company an amount sufficient to satisfy any federal, state, or local withholding tax requirements, or shall have made other arrangements satisfactory to the Company with respect to such taxes. 
 8. Nontransferability of Option. Except as provided by the following sentence, this Option is not transferable by the Optionee other than by will or the
applicable laws of descent and distribution, and is exercisable during the Optionee's lifetime only by the Optionee. Subject to the Stockholders Agreement, this Option shall be transferable to the extent permitted by Rule 701 under the Securities
Act of 1933, as amended. 
 9. Status Change. Upon the termination of the Optionee's Employment, this Option shall continue or terminate, as
and to the extent provided in the Plan. 
  

 -4- 

 10. Effect on Employment. Neither the grant of this Option, nor the issuance of Units upon exercise of this
Option, shall give the Optionee any right to be retained in the employ of the Company or its Affiliates, affect the right of the Company or its Affiliates to discharge or discipline such Optionee at any time, or affect any right of such Optionee to
terminate his or her Employment at any time. 
 11. Indemnity. Optionee hereby indemnifies and agrees to hold the Company harmless from and against
all losses, damages, liabilities and expenses (including without limitation reasonable attorneys fees and charges) resulting from any breach of any representation, warranty, or agreement of Optionee in this Agreement or any misrepresentation of
Optionee in this Agreement. 
 12. Provisions of the Plan. This Option is subject in its entirety to the provisions of the Plan, which are
incorporated herein by reference. A copy of the Plan as in effect on the date of the grant of this Option has been furnished to the Optionee. By exercising all or any part of this Option, the Optionee agrees to be bound by the terms of the Plan and
this Option. In the event of any conflict between the terms of this Option and the Plan, the terms of this Option shall control. 
 13. Definitions.
The initially capitalized terms Optionee, Initial Vesting Date and Grant Date shall have the meanings set forth on the first page of this Agreement; initially capitalized terms not otherwise defined herein shall have the meaning provided in the Plan
and the Stockholders Agreement, and, as used herein, the following terms shall have the meanings set forth below: 
 “Actual Internal EBITDA” means, with respect to a calendar year, the Company’s actual earnings before interest, taxes, depreciation and amortization for such year, determined based on the Company’s audited financials.
Actual Internal EBITDA shall also exclude (i) out of pocket expenses of the Investor that are reimbursed by the Company, (ii) non-cash gains or losses on dispositions of assets by the Company, (iii) gains or losses on interest rate
swap agreements, (iv) costs directly associated with refinancing the Company’s indebtedness or with any cash equity financing, and (v) non-cash compensation charges related to the Company’s compensation plans. Actual Internal
EBITDA shall not be reduced by costs of the acquisition of the former CRC Health Group, Inc. by the Company, management and transaction fees payable to the Investors or their Affiliates, or non-cash equity incentive expenses. Actual Internal EBITDA
shall be calculated without giving effect to purchase accounting for the acquisition of the former CRC Health Group, Inc. by the Company. For the avoidance of doubt, year 2007 shall include Actual Internal EBITDA accrued during all of calendar year
2007 attributable to all businesses owned by the Company and in operation as of January 1, 2007. 
 “Affiliate”
shall mean, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such Person. 
 “Average Vesting Percentage” means, as of any date, (i) the sum of the Vesting Percentage and Catch-up Vesting Percentage, if any for all calendar years in the Performance Period for which the Vesting
Percentage and Catch-up Vesting Percentage, 

  

 -5- 

 
if any, have been determined, divided by (ii) the number of calendar years in the Performance Period for which the Vesting Percentage and Catch-up
Vesting Percentage, if any, have been determined. 
 “Base Case” means, with respect to a specified calendar year
within the Performance Period, the Actual Internal EBITDA target for the Company for such calendar year, which target shall be adjusted from time to time in good faith by the Compensation Committee to reflect the consequences of acquisitions,
dispositions and start-ups of any new facilities and changes in GAAP promulgated by FASB or the SEC. Such adjustment by the Compensation Committee shall be made for the purpose of providing a consistent basis from year to year for computing the
relationship of Actual Internal EBITDA to the Base Case in order to prevent the dilution or enlargement of the Optionee’s rights under this Agreement. Notwithstanding the foregoing, no adjustment to the Company’s Actual Internal EBITDA
targets shall be made in respect of outpatient methadone based treatment start-ups (other than pain management start-ups for which an adjustment would be made). The initial Actual Internal EBITDA targets for the Company are set forth below:

  

																
	 Base Case
	  	2007	  	2008	  	2009	  	2010	  	2011
	 Actual Internal EBITDA (in millions)
	  	$	71.4	  	$	119.7	  	$	143.8	  	$	167.5	  	$	191.2

 For the avoidance of doubt, the target for year 2006 is a target for Actual
Internal EBITDA earned during all of calendar year 2006. 
 “Catch-up Vesting Percentage” means a percentage
determined as follows: 
 (a) for the calendar year 2007, the Catch-up Vesting Percentage will equal zero percent. 

(b) for any of calendar years 2008, 2009, 2010 or 2011, if the Historic Vesting Percentage was equal to 20%, the Catch-up Vesting
Percentage will equal zero percent; 
 (c) for any of calendar years 2008, 2009, 2010 or 2011, if the Historic Vesting
Percentage was less than 20%, the Catch-up Vesting Percentage will be an amount (expressed as a percentage) equal to (i) the product of (A) two multiplied by (B) the Revised EBITDA Percentage minus 90% minus (ii) the
Historic Vesting Percentage. For example, if the Revised EBITDA Percentage for 2007 were 98% and the Historic Vesting Percentage for 2007 were 10%, the Catch-up Vesting Percentage for such year (as determined on March 31, 2009) would be 6%.

 “Change of Control” means any Sale Transaction if immediately after giving effect to such Sale Transaction the
Investors no longer hold, directly or indirectly, at least 80% of the Investor Shares held by the Investors immediately prior to the Sale Transaction. 
  

 -6- 

 “EBITDA Percentage” means, with respect to a calendar year in the Performance
Period, the percentage obtained by dividing the Actual Internal EBITDA for such calendar year by the Base Case for that year. 
 “Excess EBITDA” means, with respect to a calendar year, the difference, if a positive number, between (i) the Actual Internal EBITDA for such calendar year minus (ii) the Base Case for such calendar year. 
 “Historic Base Case” means, with respect to a calendar year, the Base Case for the year immediately prior to such calendar year.

 “Historic EBITDA” means, with respect to a calendar year, the Actual Internal EBITDA for the year immediately
prior to such calendar year. 
 “Historic Vesting Percentage” means, with respect to a calendar year, the Vesting
Percentage for the year immediately prior to such calendar year. 
 “Initial Public Offering” means the initial
public offering of the common stock of the Company. 
 “Investor” shall have the meaning set forth in the
Stockholders Agreement. 
 “Investor Shares” has the meaning set forth in the Stockholders Agreement and shall
include any stock, securities or other property or interests received by the Investors in respect of Investor Shares in connection with any stock dividend or other similar distribution, stock split or combination of shares, recapitalization,
conversion, reorganization, consolidation, split-up, spin-off, combination, repurchase, merger, exchange of stock or other transaction or event that affects the Company’s capital stock occurring after the date of issuance. 
 “Measurement Date” means (i) the first anniversary of an Initial Public Offering, (ii) each six month anniversary
thereafter and (iii) the date of a Sale Transaction. 
 “Performance Period” means the five (5) year
period beginning on January 1, 2006. 
 “Person” shall mean any individual, partnership, corporation,
association, trust, joint venture, unincorporated organization or other entity. 
 “Revised EBITDA Percentage”
means, with respect to a calendar year in the Performance Period, the lower of (A) the percentage obtained by dividing (i) the sum of Excess EBITDA for such calendar year plus Historic EBITDA with respect to such calendar year by
(ii) the Historic Base Case with respect to such calendar year or (B) 100%. 
 “Sale Transaction” shall
mean: (i) any change in the ownership of the capital stock of the Company (whether by way of sale of stock, merger, or otherwise) if, immediately after giving effect thereto, any Person (or group of Persons acting in 

  

 -7- 

 
concert) other than the Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of the Board, or (ii) a
sale or transfer of all or substantially all of the Company’s assets to a Person who is not a subsidiary of the Company. 
 “Tranche 2 Maximum Percentage” means (i) 33 1/3rd % on the first anniversary of an Initial Public Offering, (ii) 66 2/3rds % on the eighteen month anniversary of an Initial Public Offering, and (iii) 100% on a Sale Transaction or any Measurement Date after the eighteen month anniversary of an Initial Public Offering. 

 “Tranche 2 Vesting Event” means, with respect to a Measurement Date, that the Unit Value equals or exceeds
$180 on such Measurement Date. 
 “Tranche 3 Vesting Event” means, with respect to a Measurement Date, that the Unit
Value equals or exceeds $360 on such Measurement Date after giving effect to any vesting of Tranche 2 Options under this or any similar option agreement. 
 “Undetermined Years” means, as of any date, the number of calendar years in the Performance Period for which the Vesting Percentage has not been determined. 
 “Unit Value” means (i) upon a Sale Transaction, the fair market value, as determined in good faith by the Board, of a Unit
(including any shares or other securities issued upon conversion of or in respect of such Unit) plus the aggregate of any dividends or distributions in respect of such Unit from and after February 6, 2006 and (ii) on any other Measurement
Date, the average of the closing price of a Unit (including any shares or other securities issued upon conversion of or in respect of such Unit) for the 180 days prior to such date on which the relevant market was open for trading, plus the
aggregate of any dividends and distributions in respect of such Unit from and after February 6, 2006. 
 “Vesting
Percentage” means, with respect to a calendar year, a percentage determined as follows: 
 (a) if the EBITDA
Percentage for such calendar year is less than or equal to 90%, the Vesting Percentage will equal zero percent; 
 (b) if
the EBITDA Percentage for such calendar year is equal to or greater than 100%, the Vesting Percentage will equal 20 percent; and 
 (c) if the EBITDA Percentage for such calendar year is between 90% and 100%, the Vesting Percentage will equal the product (expressed as a percentage) of (i) two multiplied by (ii) the EBITDA Percentage for such calendar year
minus 90%. For example, if the EBITDA Percentage for a calendar year were 97%, the Vesting Percentage for such year would be 14%. 
 14. General. For
purposes of this Option and any determinations to be made by the Administrator or Compensation Committee, as the case may be, hereunder, the determinations by the Administrator or Compensation Committee, as the case may be, shall be binding upon the
Optionee and any transferee. 
  

 -8- 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 -9- 

 IN WITNESS WHEREOF, the Company has caused this Option to be executed under its corporate seal by its
duly authorized officer. This Option shall take effect as a sealed instrument. 
  

			
	CRC HEALTH GROUP, INC.
		
	By:	 	  

	Name:	 	Dr. Barry Karlin
	Title:	 	Chairman and CEO

  

	
	Dated:
	
	Acknowledged and Agreed
	
	  

	Name:
	
	Address of Principal Residence:Agreement dated September 20, 2007 by and between Elliot Sainer

 Exhibit 10.19 
 AGREEMENT 
 This Agreement (the “Agreement”) dated as of September 20, 2007 and
with an effective date of October 1, 2007 (“Effective Date”) by and between Elliot A. Sainer (“Sainer”), CRC Health Group, Inc. (“Group”), CRC Health Corporation
(“Company”) and Aspen Education Group, Inc. (“Aspen”). 
 WHEREAS, Sainer currently serves as Chief Executive
and President of Aspen pursuant to the terms of an Employment Agreement between Aspen and Sainer dated February 1, 2004, as amended November 17, 2006 (the “Employment Agreement”). 
 WHEREAS, Sainer currently serves as a member of the Board of Directors of each of Group, the Company and Aspen. 
 WHEREAS, Sainer shall retire from Aspen but continue to serve as a consultant and member of the Board of Directors for Group and the Company. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
 1. Resignation; Employment Agreement; Option Matters. 
  

	 	A.	Effective as of immediately prior to the Effective Date, (i) the Employment Agreement is terminated; (ii) Sainer resigns as Chief Executive Officer and President of Aspen
and from any other office he holds at Group or any entity controlled by Group (an “Affiliate”) and (iii) Sainer resigns as a member of the board of directors of each Affiliate (other than the Company) on which he serves
immediately prior to the Effective Date. 

  

	 	B.	Except as provided in the Employment Agreement, all benefits provided by Group or any of its Affiliates to Sainer cease as of the Effective Date. Sainer will no longer be eligible
to participate in any benefit plans sponsored or provided by Group or any of its Affiliates, including but not limited to 401(k) plans, vision plans or other similar insurance plans, and Sainer will no longer be eligible to participate in the bonus
plan of Group or any of its Affiliates. Because it is a requirement under the Company’s bonus plan that a person be an employee at the time that any bonus is paid, Sainer agrees that he is not be eligible to receive any bonus under any bonus
plan offered by Group or its Affiliates for any portion of 2007. 

  

	 	C.	On the Effective Date, options issued to Sainer to purchase 12,933 Units pursuant to the Senior Executive Option Certificate granted November 17, 2007 (the “Sainer
Option”) shall be automatically forfeited. The remaining 5,543 Units subject to the Sainer Option will be allocated 50% to Tranche 1, 25% to Tranche 2 and 25% to Tranche 3 and shall vest subject to the terms of the Sainer Option as
modified by the terms set forth in Subsection 1(D) and Subsection 4(B). 

	 	 D.
	 For purposes of the Substitute Option Certificate issued to Sainer on November 17, 2007 (“Sainer
Rollover Option”) and the Sainer Option, Sainer’s “Employment” (as defined in the 2006 Executive Plan) shall be deemed to extend to the later of (i) the term of this Agreement or (ii) Sainer’s term on the
Board of Directors of Group. Further, for purposes of Section 5 of the Stockholder’s Agreement dated February 6th, 2006 (as amended from
time to time, the “Stockholders Agreement”), the term “employment” as used in Section 5.1 shall be deemed to extend to the later of (i) the term of this Agreement or (ii) Sainer’s term on the
Board of Directors of Group. 

 2. Board Services of Sainer. Subject to the terms and conditions of the Stockholders
Agreement, the organizational documents of such entities and the Delaware General Corporation Law, Sainer shall (i) continue to serve as a member of the Board of Directors of Group and the Company (the “Board Services”)
and (ii) serve as Vice-Chairman of the Board of Directors of Group and the Company. 
 3. Consulting Services. Sainer agrees to furnish the
following services (the “Consulting Services”) to the Company, beginning on the Effective Date: 
  

	 	A.	Consulting services as more particularly detailed on Exhibit A to this Agreement, on a schedule of approximately forty (40) hours per month on a schedule that is
mutually agreeable to the parties. Additional hours may be proposed by either party, provided neither party shall be obligated to provide services or compensation for more than forty (40) hours per month unless mutually agreed in writing
between the Sainer and the CEO of the Company. 

  

	 	B.	At all times during the term of and subject to the provisions of this Agreement, Sainer shall devote sufficient time and energy to the performance of the Consulting Services to
fulfill those responsibilities in good faith and consistent with the terms and conditions of this Agreement. The parties acknowledge that Sainer may enter into other business ventures that require his time, provided they do not interfere or conflict
with his obligations hereunder or pursuant to Sections 8, 9 and 10 of the Employment Agreement. 

 4. Compensation. In consideration of
the Consulting Services and Board Services, the Company agrees to pay Sainer following the Effective Date on the following basis. 
  

	 	A.	For Consulting Services, Sainer shall receive a monthly fee of Five Thousand dollars ($5,000.00), payable fifteen (15) days following the end each month Services are rendered
pursuant to the terms of this Agreement. 

  

	 	B.	 After giving effect to the forfeiture described in Subsection 1(C) above, Sainer shall retain an option to purchase a total of 5,543 Units pursuant to the Sainer
Option. Of that total, notwithstanding anything to the contrary in the Sainer Option, the 2006 Executive Plan, this Agreement or otherwise, the option to 

  

 2 

	 	 
purchase 2,771.5 Units (the “Consulting Portion”) shall only continue to vest pursuant to the terms of the Sainer Option so long as
Sainer continues to provide Consulting Services pursuant to this Agreement and the option to purchase the other 2,771.5 Units (the “Board Service Portion”) shall only continue to vest pursuant to the terms of the Sainer
Option so long as Sainer continues to provide Board Services. Both the Consulting Portion and the Board Service Portion shall be allocated 50% to Tranche 1, 25% to Tranche 2 and 25% to Tranche 3. 

  

	 	C.	No per diem or standard hourly rates will be paid other than those listed above and no adjustment to the compensation shall be made unless agreed to in writing by the undersigned
parties. 

  

	 	D.	Upon termination of this Agreement for any reason, Sainer will be paid fees that are incurred prior to the termination and reimbursed for expenses approved in accordance with
Section 10 of this Agreement. 

 In order to meet federal regulations concerning tax reporting requirements, Sainer shall
furnish the Company with either a Social Security Number or Federal Tax Identification Number. 
 5. Term and Termination. The term of this Agreement
shall be from October 1, 2007 until September 30, 2008, and shall automatically renew for successive one year renewal terms, subject to termination as stated in the following sentence. This Agreement may be terminated at any time
(i) by either party on sixty (60) days written notice to the other or (ii) by the Company at its sole discretion for cause arising out of the non-performance of the services or duties described herein, or for violation of any Company
policy or procedure, following written notice and if practicable under the circumstances, a cure period of fourteen (14) days. The rights and obligations contained in this Section and Sections 4(B) (to the extent such options are vested as of
the termination of this Agreement), 6(A), 12, 13 and 18 will survive termination or expiration of this Agreement. 
 6. Requirements. 
  

	 	A.	Sainer is required to uphold all current HIPAA (the Health Insurance Portability and Accountability Act, April 14, 2003) and 42 CFR Part Two for those patients receiving
behavioral, drug/alcohol treatment regulations, policies and procedures, as well as the current policies and procedures of the Company, as may be amended from time to time. 

  

	 	B.	Sainer shall notify Company of any material non-compliance with respect to the requirements of this Section 6, or of any litigation or government investigation or inquiry that
arises in connection with the services provided hereunder. Sainer shall report, and provide full disclosure of facts pertaining to, Company any conflict or potential conflict of interest of Sainer in connection with the services.

  

	 	C.	 Sainer shall not discriminate against any student/patient because of race, color, 

  

 3 

	 	 
ethnicity, national origin, citizenship, age, sex, religion, or physical or mental disability, except to the extent that a circumstance such as age, sex or
disability is significant to the provision of appropriate Company services to the client. 

 7. Compliance With Law. Sainer shall
comply with all federal, state and local laws respecting the conduct of his business and profession, including but not limited to any federal and state laws governing the referral of patients which are in effect or will become effective during the
term of this Agreement. Nothing in this Agreement is intended or shall be construed to require either Company or Sainer to violate any provision of state or federal law. 
 8. Performance of Consulting Services. Sainer reserves the right to control or direct the manner in which services are to be performed. Subject to the foregoing, the Company reserves the right to inspect, stop
work, alter, and generally supervise the Services to ensure its conformity with that specified in this Agreement. Sainer shall report to the Chief Executive Officer of Group. 
 9. Place of Work. Sainer shall render the Consulting Services at such places as appropriate for the performance of particular services, and shall not be required to perform the services at the premises of the
Company unless necessary for any particular aspect of a service. Sainer shall be entitled to use of the phone numbers (562) 467-5507, (626) 622-4422 and mobile phone equipment and the email address (esainer@aspeneducation.com)
and remote access thereto in connection with his performance of Consulting Services during the term hereof. 
 10. Expenses. Sainer shall be
reimbursed for his out-of-pocket costs and expenses that directly result from the performance of his Consulting Services and Board Services and are approved by the Chief Executive Officer of Group, in accordance with the expense reimbursement
policies of the Company as in effect from time to time, except that any expenses such as taxes or licensing fees required of or imposed against Sainer, and all other basic costs of Sainer’s conduct of his business, such as business equipment or
general overhead costs shall be the responsibility of Sainer. 
 11. Tools and Supplies. Sainer shall be solely responsible for procuring, paying for
and maintaining any supplies necessary or appropriate for the performance of the Consulting Services hereunder unless otherwise agreed to between Sainer and Company. 
 12. Confidential Information. Sainer acknowledges that in connection with the services to be performed hereunder, he may receive or have access to information that may consist of Confidential Information. As
used in this Agreement, the term “Confidential Information” shall mean: (a) information related to the Company’s patients, clients and family members; (b) proprietary information, intellectual property, and
trade secrets of Company; (c) information marked or designated by Company as confidential; (d) information, whether or not in electronic or written form and whether or not designated as confidential, which is known to Sainer as being
treated as confidential by the Company; (e) all individually identifiable health care information of Company’s clients and patients, including without limitation any information which may be obtained or compiled in the operation of any
system to identify patients in order to detect and 

  

 4 

 
protect against multiple registrations (“Protected Health Information”); or (f) information provided to Sainer concerning the
Company or third parties which Sainer is obligated to keep confidential. 
  

	 	A.	Ownership. Sainer acknowledges that the Company’s Confidential Information is and shall continue to be the exclusive property of the Company, whether or not disclosed,
entrusted to or developed by Sainer pursuant to this Agreement. 

  

	 	B.	Covenant of Nondisclosure. Sainer agrees not to disclose the Company’s Confidential Information, directly or indirectly, under any circumstances or by any means, to any
third person without the express written consent of the Company. 

  

	 	C.	Sainer shall, at all times preserve the confidentiality of all Protected Health Information and shall use and disclose Protected Health Information only for the limited purposes
necessary for the performance of Services, and as permitted by all applicable state and federal privacy protections, including but not limited to 21 U.S.C.A. § 823, 42 U.S.C.A. § 290aa et seq., Title 42 (commencing with Section 2.1)
of the Code of Federal Regulations, Title 42 (commencing with Section 8.1) of the Code of Federal Regulations and the Health Insurance Portability and Accountability Act of 1996. 

 13. Company Innovations. Sainer does and will assign to Company, and take such steps as are necessary to effectuate such assignment, all of Sainer’s right,
title and interest in and to any and all processes, policies and procedures, inventions, improvements, discoveries, developments, trade secrets or other intellectual property conceived, developed or reduced to practice by Sainer solely in connection
with, or as a result of, the services performed for the Company pursuant to this Agreement and shall treat all such information as Confidential Information of the Company. 
 14. Workers’ Compensation. No Workers’ Compensation insurance will be obtained by the Company for or on behalf of Sainer. Sainer agrees to provide a copy of his Workers’ Compensation
insurance certificate, or will complete the necessary Workers’ Compensation waiver forms releasing the Company from any responsibility for providing such Workers’ Compensation insurance. Sainer agrees to hold harmless and indemnify the
Company for any and all claims arising out of any injury, disability or death of Sainer or any employee or agent of Sainer.  
 15. [Intentionally
Ommitted] 
 16. Legal Procedures. Both Sainer and Company agree to use arbitration, with a mutually agreed upon arbitrator, as an initial methodology
of problem resolution, should questions arise concerning enforcement of any terms, covenants, or conditions of this Agreement. If any party hereto finds it necessary to employ legal counsel or to bring a lawsuit or other proceedings against any
other party to enforce any of the terms, covenants or conditions hereof, the party prevailing in such action or other proceedings shall be paid all reasonable attorney’s fees by the other party, as deemed by the court and not the jury, and in
the event any judgment is secured by such prevailing party, all such attorney’s fees shall be included in any such judgment in such action or proceedings. 
  

 5 

 17. Independent Sainer Relationship. Sainer’s relationship with Company is that of an independent contractor,
and nothing in this Agreement is intended to, or shall be construed to, create a partnership, agency, joint venture, employment or similar relationship. Except as expressly stated herein, Sainer will not be entitled to any of the benefits stated in
Section 4 of the Employment Agreement or that Company may make otherwise available to its employees, including, but not limited to, group health or life insurance, profit-sharing or retirement benefits. Sainer is not authorized to make any
representation, contract or commitment on behalf of Company unless specifically requested or authorized in writing to do so by a Company manager. Sainer is solely responsible for, and will file, on a timely basis, all tax returns and payments
required to be filed with, or made to, any federal, state or local tax authority with respect to the performance of services and receipt of fees under this Agreement. Sainer is solely responsible for, and must maintain adequate records of, expenses
incurred in the course of performing services under this Agreement. No part of Sainer’s compensation will be subject to withholding by Company for the payment of any social security, federal, state or any other employee payroll taxes. Company
will regularly report amounts paid to Sainer by filing Form 1099-MISC with the Internal Revenue Service as required by law. 
 18. Noncompetition and
Nonsolicitation Covenant. Notwithstanding the provisions of Section 6(e)(iii) and Section 10 of the Employment Agreement, Sainer hereby covenants and agrees that Sainer’s obligations pursuant to Section 10 of the Employment
Agreement shall continue to the later of (i) the termination of the Employment Period (as defined in the Employment Agreement), or (ii) three months after the later of (x) termination of this Agreement or (y) termination of
Sainer’s services as a member of the Board of Directors of the Company. Sainer agrees to notify the CEO of the Company in the event that Sainer desires to engage in, have an interest in or otherwise be involved with any company in the
behavioral health field (excluding any interest as contemplated by Section 10(b) of the Employment Agreement). 
 19. Substitution/Assignment. No
substitution or assignment for the Services or the person named as Sainer herein will be allowed without prior written consent of the Company. 
 20.
Entire Agreement; Amendment. This Agreement constitutes the entire and whole agreement between the parties and supersedes all other agreements, oral or written, previously entered into with respect to the consulting relationship between the
parties; the parties acknowledge and agree that except as specifically set forth in this Agreement, the provisions of the Employment Agreement, the Sainer Option, the Sainer Rollover Option and the Stockholder’s Agreement and any other
agreement between Sainer and the Company remain in full force and effect. For the elimination of doubt, subject to the terms of the Employment Agreement, Sainer shall be entitled to receive the payments described in Section 6(d) of the
Employment Agreement for the time period stated therein. This Agreement may not be modified or amended except by a written instrument, signed by each of the parties executing such amendment or modification. 
  

 6 

 21. Notices; Delivery. All notices, requests, demands and other communications hereunder shall be in writing and
shall be deemed to have been duly given if, in the case of notices given to the Company, any such communication is addressed/delivered to: 
 CRC Health Group, Inc. 
 20400 Stevens Creek Blvd., Suite #600 
 Cupertino, CA 95014 
 Attention: Chief
Executive Officer 
 With a copy to General Counsel via facsimile 415-358-8444 
 In the case of notices given by the Company, any such communication shall be addressed and/or delivered to Sainer at the address set forth on the
signature page. 
 22. Law Governing. This Agreement shall, in all respects, be governed by the laws of the State of California, excluding its
conflicts of law. 
  

 7 

 THIS AGREEMENT SHALL BE EFFECTIVE AS OF THE EFFECTIVE DATE DESCRIBED ABOVE. 
  

							
	BY:	 		  		 	
	Sainer	 		  	CRC Health Group, Inc.
	 /s/ Elliot A. Sainer
	  	 /s/ Barry Karlin

	Print Name:	 	Elliot A. Sainer	  	Print Name:	 	Barry Karlin
	Date:	 	  
	  	Title:	 	Chief Executive Officer
	Address:	 	  
	  	Date:	 	September 20, 2007
	  
	  		 	
		 		  	CRC Health Corporation
		 		  	 /s/ Barry Karlin

		 		  	Print Name:	 	 Barry Karlin

		 		  	Title:	 	Chief Executive Officer
		 		  	Date:	 	September 20, 2007
			
		 		  	Aspen Education Group, Inc.
		 		  	 /s/ Kevin Hogge

		 		  	Print Name:	 	Kevin Hogge
		 		  	Title:	 	Chief Financial Officer
		 		  	Date:	 	September 20, 2007

  

 8 

 Exhibit A 
 Description of Services 
 As directed by the Chief Executive Officer of Group: 
 a. Mentor 3-4 individuals, both within Aspen and other CRC divisions, for leadership within CRC. 
 b. Assist CRC’s deal team on acquisitions in the youth service area. 
 c. Transitional guidance to President of Aspen
division. 
 d. Consult with CRC’s CEO on strategy planning, business development, and management challenges and topics. 
 e. Represent Aspen/CRC to the referral community. Periodically meet with key referral sources as well as represent CRC and Aspen to some of the key organizations that
Aspen and CRC interact with nationally. 
 g. Represent CRC at several speaking engagements, and during a transitional period on the NAPHS Board. 

h. Such other services as the parties shall mutually agree on behalf of Group and its Affiliates. 
  

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]